RT @BioMedCentral: Sodium-glucose cotransporter 2 inhibitors use reduces risks of overall respiratory events, pneumonia, and respiratory fa…
9,408 followers
77,162 followers
Sodium-glucose cotransporter 2 inhibitors use reduces risks of overall respiratory events, pneumonia, and respiratory failure compared to dipeptidyl peptidase 4 inhibitors use in patients with type 2 diabetes, reports a study in @BMCMedicine. https://t.co/
15 followers
RT @BMCMedicine: Real-world evidence from Korea suggests a lower risk of adverse #respiratory events with #SGLT2i versus #DPPi among patie…
9,408 followers
Real-world evidence from Korea suggests a lower risk of adverse #respiratory events with #SGLT2i versus #DPPi among patients with type 2 #diabetes https://t.co/v5n1pdbcJu Evidence-based research from @SSKUniversity on #SGLT2 inhibitors #diabetestwitter